Bolt Biotherapeutics is a United States biotechnology company focused on developing immunotherapies for cancer. Its research platform is designed to engage the immune system through antibody-based approaches and related therapeutic candidates.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!